November 6, 2015
8 to 8:20 a.m.
8:20 to 8:30 a.m.
Steven Rosen, M.D.
Provost, City of Hope
Director, Beckman Research Institute
8:30 to 9:20 a.m.
Microbiota-mediated Defense against Intestinal Colonization by Antibiotic-resistant Pathogens
Eric G. Pamer, M.D., Memorial Sloan Kettering Cancer Center
9:20 to 10:10 a.m.
Discovery of a Potential Probiotic Therapy for Autism
Sarkis K. Mazmanian, Ph.D., California Institute of Technology
10:10 to 10:30 a.m.
10:30 to 11:20 a.m.
Long-term Consequences of Host-Microbiota Interactions
Yasmine Belkaid, Ph.D., National Institute of Allergy and Infectious Diseases, NIH
11:20 a.m. to 12:10 p.m.
Frenemies in the Gut—Infectious Agents that Defy Classification
Ken Cadwell, Ph.D., Skirball Institute, NYU School of Medicine
12:10 to 1:10 p.m.
1:10 to 2 p.m.
Biofilms, Genetics, and Colon Cancer
Cynthia L. Sears, M.D., Johns Hopkins University
2 to 2:50 p.m.
Bugs, Drugs, and Stem Cells
Ami S. Bhatt, M.D., Ph.D., Stanford University
2:50 to 3:40 p.m.
Systems Biology, Modeling, and Cross-meta-omic Analysis of the Human Microbiome
Elhanan Borenstein, Ph.D., University of Washington
3:40 to 4 p.m.
4 to 4:50 p.m.
Host Microbiome Interactions in Health and Disease
Eran Elinav, M.D., Ph.D., Weizmann Institute of Science, Rehovot, Israel
4:50 to 5:40 p.m.
Predicting and Preventing Drug Metabolism by the Human Gut Microbiome
Peter J. Turnbaugh, Ph.D., University of California, San Francisco